13 results
DRSLTR
STRO
Sutro Biopharma Inc
8 Aug 18
Correspondence regarding draft registration statement
12:00am
, the broad diversity of the programs in the Company’s pipeline, which comprises antibody-drug conjugates, bispecific antibodies and cytokine derivatives
PRE 14A
STRO
Sutro Biopharma Inc
14 Apr 23
Preliminary proxy
4:05pm
candidates, including such factors as business experience, diversity and personal skills in life sciences and biotechnology, finance, marketing … for nomination for reelection, the Nominating and Governance Committee considers director tenure. We value diversity on a company-wide basis but have not yet
8-K
EX-99.1
iq3locd i1ea
13 Nov 23
Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
DEF 14A
14f gnngfbgem
26 Apr 19
Definitive proxy
12:00am
- Prev
- 1
- Next